Variation in assistive technology use in motor neuron disease according to clinical phenotypes and ALS functional rating scale - Revised score

A prospective observational study

Karol Connors, Lisa Mahony, Prue Morgan

Research output: Contribution to journalArticleResearchpeer-review

Abstract

BACKGROUND: Assistive devices enhance independence and quality of life for people living with motor neuron disease (MND), but prescription can be challenging. OBJECTIVE: Improved prescription of assistive devices, through improved understanding of the relationship between clinical phenotypes, Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) functional domain sub-scores and assistive technology required by people living with MND. METHODS: Prospective, observational consecutive-sample study of 269 patients with MND diagnosis. Main outcome measures: MND phenotype, ALSFRS-R scores and assistive technology devices in use. RESULTS: A statistically significant difference in total concurrent assistive technology item use was found between phenotypes (p = 0.001), with those with ALS Bulbar onset using the least. There was also a statistically significant difference in assistive technology usage in five of seven assistive technology categories across the clinical phenotypes, namely orthoses (p < 0.000), mobility devices (p < 0.000), transfer devices (p < 0.000), communication devices (p < 0.000), and activities of daily living devices (p = 0.016). Correlations between ALSFRS-R sub-score items and assistive technology count confirmed the utility of this outcome measure for equipment prescription. CONCLUSIONS: Clinicians need to consider MND phenotype and/or ALSFRS-R domain sub-score in clinical decisionmaking regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required.

Original languageEnglish
Pages (from-to)303-313
Number of pages11
JournalNeuroRehabilitation
Volume44
Issue number2
DOIs
Publication statusPublished - 2019

Keywords

  • ALS
  • ALSFRS-R
  • Amyotrophic lateral sclerosis
  • Assistive technology
  • MND
  • Motor neuron disease

Cite this

@article{99a13e3c5c324fe08564a341a606fa22,
title = "Variation in assistive technology use in motor neuron disease according to clinical phenotypes and ALS functional rating scale - Revised score: A prospective observational study",
abstract = "BACKGROUND: Assistive devices enhance independence and quality of life for people living with motor neuron disease (MND), but prescription can be challenging. OBJECTIVE: Improved prescription of assistive devices, through improved understanding of the relationship between clinical phenotypes, Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) functional domain sub-scores and assistive technology required by people living with MND. METHODS: Prospective, observational consecutive-sample study of 269 patients with MND diagnosis. Main outcome measures: MND phenotype, ALSFRS-R scores and assistive technology devices in use. RESULTS: A statistically significant difference in total concurrent assistive technology item use was found between phenotypes (p = 0.001), with those with ALS Bulbar onset using the least. There was also a statistically significant difference in assistive technology usage in five of seven assistive technology categories across the clinical phenotypes, namely orthoses (p < 0.000), mobility devices (p < 0.000), transfer devices (p < 0.000), communication devices (p < 0.000), and activities of daily living devices (p = 0.016). Correlations between ALSFRS-R sub-score items and assistive technology count confirmed the utility of this outcome measure for equipment prescription. CONCLUSIONS: Clinicians need to consider MND phenotype and/or ALSFRS-R domain sub-score in clinical decisionmaking regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required.",
keywords = "ALS, ALSFRS-R, Amyotrophic lateral sclerosis, Assistive technology, MND, Motor neuron disease",
author = "Karol Connors and Lisa Mahony and Prue Morgan",
year = "2019",
doi = "10.3233/NRE-182511",
language = "English",
volume = "44",
pages = "303--313",
journal = "NeuroRehabilitation",
issn = "1053-8135",
publisher = "IOS Press",
number = "2",

}

Variation in assistive technology use in motor neuron disease according to clinical phenotypes and ALS functional rating scale - Revised score : A prospective observational study. / Connors, Karol; Mahony, Lisa; Morgan, Prue.

In: NeuroRehabilitation, Vol. 44, No. 2, 2019, p. 303-313.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Variation in assistive technology use in motor neuron disease according to clinical phenotypes and ALS functional rating scale - Revised score

T2 - A prospective observational study

AU - Connors, Karol

AU - Mahony, Lisa

AU - Morgan, Prue

PY - 2019

Y1 - 2019

N2 - BACKGROUND: Assistive devices enhance independence and quality of life for people living with motor neuron disease (MND), but prescription can be challenging. OBJECTIVE: Improved prescription of assistive devices, through improved understanding of the relationship between clinical phenotypes, Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) functional domain sub-scores and assistive technology required by people living with MND. METHODS: Prospective, observational consecutive-sample study of 269 patients with MND diagnosis. Main outcome measures: MND phenotype, ALSFRS-R scores and assistive technology devices in use. RESULTS: A statistically significant difference in total concurrent assistive technology item use was found between phenotypes (p = 0.001), with those with ALS Bulbar onset using the least. There was also a statistically significant difference in assistive technology usage in five of seven assistive technology categories across the clinical phenotypes, namely orthoses (p < 0.000), mobility devices (p < 0.000), transfer devices (p < 0.000), communication devices (p < 0.000), and activities of daily living devices (p = 0.016). Correlations between ALSFRS-R sub-score items and assistive technology count confirmed the utility of this outcome measure for equipment prescription. CONCLUSIONS: Clinicians need to consider MND phenotype and/or ALSFRS-R domain sub-score in clinical decisionmaking regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required.

AB - BACKGROUND: Assistive devices enhance independence and quality of life for people living with motor neuron disease (MND), but prescription can be challenging. OBJECTIVE: Improved prescription of assistive devices, through improved understanding of the relationship between clinical phenotypes, Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) functional domain sub-scores and assistive technology required by people living with MND. METHODS: Prospective, observational consecutive-sample study of 269 patients with MND diagnosis. Main outcome measures: MND phenotype, ALSFRS-R scores and assistive technology devices in use. RESULTS: A statistically significant difference in total concurrent assistive technology item use was found between phenotypes (p = 0.001), with those with ALS Bulbar onset using the least. There was also a statistically significant difference in assistive technology usage in five of seven assistive technology categories across the clinical phenotypes, namely orthoses (p < 0.000), mobility devices (p < 0.000), transfer devices (p < 0.000), communication devices (p < 0.000), and activities of daily living devices (p = 0.016). Correlations between ALSFRS-R sub-score items and assistive technology count confirmed the utility of this outcome measure for equipment prescription. CONCLUSIONS: Clinicians need to consider MND phenotype and/or ALSFRS-R domain sub-score in clinical decisionmaking regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required.

KW - ALS

KW - ALSFRS-R

KW - Amyotrophic lateral sclerosis

KW - Assistive technology

KW - MND

KW - Motor neuron disease

UR - http://www.scopus.com/inward/record.url?scp=85064828837&partnerID=8YFLogxK

U2 - 10.3233/NRE-182511

DO - 10.3233/NRE-182511

M3 - Article

VL - 44

SP - 303

EP - 313

JO - NeuroRehabilitation

JF - NeuroRehabilitation

SN - 1053-8135

IS - 2

ER -